+ Include: 10 videos + 10 audios, size: 1.27 GB
+ Target Audience: hematologists/oncologists, hospitalists, internal medicine physicians
+ Sample video: contact me for sample video
+ Information:
A concentrated, practice-focused update spanning benign and malignant hematology. Expert-led, case-based lectures translate evolving evidence and guidelines into clear diagnostic and treatment strategies you can apply immediately in clinic, hospital, and infusion settings.
What You Will Learn
How to streamline workups for anemia, cytopenias, coagulopathies, and thrombophilias
Evidence-based management of VTE: anticoagulant selection, duration, peri-procedural strategies
Current standards for leukemia, lymphoma, and myeloma—including frontline, relapsed/refractory, and maintenance approaches
Transfusion medicine pearls: product selection, thresholds, complications, and stewardship
Practical updates on targeted agents, immunotherapies, and cellular therapies—and how to manage toxicities
Supportive care essentials: infection prophylaxis, tumor lysis, TLS/SOS/VOD, and survivorship considerations
Event Details
Format: Live lectures with case discussions, board-style Q&A, and practical take-home checklists
Designed for: Rapid implementation in community and academic settings
Materials: Slide handouts and concise summaries for quick reference
Who Should Attend
Hematologists/oncologists, hospitalists, internal medicine physicians, advanced practice providers, pharmacists, and fellows seeking a high-yield, clinically oriented hematology refresh.
Why Attend
Convert complex trials and guidelines into simple, usable algorithms
Update your approach to diagnostics, therapeutics, and toxicity management
Leave with pragmatic tools to improve quality, safety, and patient outcomes
+ Topics:
Saturday, February 17, 2024 | ||
TIME | TOPIC | PRESENTER |
07:00 AM – 08:00 AM | Breakfast | Visit Exhibit Hall | Exhibitors | Attendees |
08:00 AM – 08:15 AM | Welcome | Introduction to Program | Robert S. Siegel, MD Professor of Medicine, Associate Center Director for Education and Training, The George Washington University, GW Cancer Center |
08:15 AM – 09:00 AM | Myeloproliferative Neoplasms | Ayalew Tefferi, MD Barbara Woodward Lips Professor of Medicine, Mayo Clinic |
09:00 AM – 09:45 AM | Multiple Myeloma | Kenneth Anderson, MD Kraft Family Professor of Medicine Dana-Farber Cancer Institute, Harvard Medical School |
09:45 AM – 10:00 AM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
10:00 AM – 10:45 AM | Disorders of Coagulation | Kenneth A. Bauer, MD Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center |
10:45 AM – 11:30 AM | Acute Myeloid Leukemia | Samah Nassereddine, MD Assistant Professor of Medicine, The George Washington University, GW Cancer Center |
11:30 AM – 12:15 PM | Bone Marrow Failure Syndromes, PNH, and MDS | Amy DeZern, MD, MHS Associate Professor The Johns Hopkins University School of Medicine |
12:15 PM – 01:15 PM | Lunch | Visit Exhibit Hall | Exhibitors | Attendees |
12:15 PM – 01:15 PM | Lunch Product Forum sponsored by Pfizer | Speaker- TBC |
01:15 PM – 02:00 PM | Chronic Lymphocytic Leukemia | Imad A. Tabbara, MD Chief, Division of Hematology/Oncology of DeCesaris Cancer Institute, Anne Arundel Medical Center, Clinical Professor of Medicine, The George Washington University |
02:00 PM – 02:45 PM | Lymphoma | Nina Delaney Wagner-Johnston, MD Director of Lymphoma Drug Development, The Sidney Kimmel Comprehensive Cancer Center, Professor of Oncology, The Johns Hopkins University School of Medicine |
02:45 PM – 03:30 PM | Cellular Therapies | Catherine Bollard, MBChB, MD, FRACP, FRCPA Professor of Pediatrics, Director, Center for Cancer and Immunology Research, Children’s National Hospital and The George Washington University |
03:30 PM – 03:35 PM | Closing Remarks | Adjournment | Robert S. Siegel, MD Professor of Medicine, Associate Center Director for Education and Training, The George Washington University, GW Cancer Center |